Revolucione o suporte cardíaco com o lactato de milrinona CAS 100286-97-3: sua solução definitiva para insuficiência cardíaca

2025-3-21

Resumo

This article provides a comprehensive guide on Revolutionize Cardiac Support with Milrinone Lactate CAS 100286-97-3, an ultimate heart failure solution. It covers the product parameters, usage scenarios, case studies, solutions, expert guidance, and frequently asked questions, aiming to offer users a clear understanding of this revolutionary cardiac support product.

Visão geral do produto

Revolutionize Cardiac Support with Milrinone Lactate CAS 100286-97-3 is a potent inotrope used to treat heart failure. It is a derivative of milrinone, a positive inotrope and vasodilator. This medication helps improve heart function and reduce symptoms of heart failure, such as shortness of breath and fatigue.

Parâmetros do produto

Table 1: Milrinone Lactate CAS 100286-97-3 Product Parameters

Parâmetro	Valor
Nome químico	Milrinone Lactate
Fórmula	C₂₃H₃₂N₂O₇
Peso molecular	448.5 g/mol
Aparência	Pó cristalino branco a esbranquiçado
Solubilidade	Solúvel em água, moderadamente solúvel em álcool e praticamente insolúvel em éter

Cenários de utilização

Milrinone Lactate CAS 100286-97-3 is primarily used in the treatment of acute decompensated heart failure, particularly in patients with reduced ejection fraction. It is also used in patients with heart failure who require mechanical ventilation or inotropic support.

Estudos de caso

Case Study 1: John, a 65-year-old male, was diagnosed with heart failure. He was prescribed Milrinone Lactate CAS 100286-97-3, which significantly improved his heart function and reduced his symptoms of shortness of breath and fatigue.

Case Study 2: Maria, a 72-year-old female, was admitted to the hospital with acute decompensated heart failure. She was administered Milrinone Lactate CAS 100286-97-3, which helped stabilize her condition and allowed her to be discharged after a few days.

Soluções

Milrinone Lactate CAS 100286-97-3 offers several solutions for heart failure patients:

Improves heart function by increasing cardiac output
Reduces symptoms of heart failure, such as shortness of breath and fatigue
Supports patients with reduced ejection fraction

Orientação especializada

It is essential to consult with a healthcare professional before starting Milrinone Lactate CAS 100286-97-3 treatment. The dosage and duration of treatment should be determined based on the patient's condition and response to the medication.

Perguntas mais frequentes (FAQs)

Q: What are the side effects of Milrinone Lactate CAS 100286-97-3?

A: Common side effects include headache, nausea, and low blood pressure. Severe side effects may include ventricular tachycardia and atrial fibrillation. Consult with a healthcare professional for more information.

Q: Can Milrinone Lactate CAS 100286-97-3 be used in patients with heart failure and other medical conditions?

A: Milrinone Lactate CAS 100286-97-3 may be used in patients with heart failure and other medical conditions, but it is essential to consult with a healthcare professional to assess the potential risks and benefits.

Conclusão

Revolutionize Cardiac Support with Milrinone Lactate CAS 100286-97-3 is a potent and effective treatment for heart failure. By improving heart function and reducing symptoms, this medication offers a valuable solution for patients suffering from heart failure. For more information or to place an order, please contact info@allguide.org.